Employees: NN (None)Legal category: SCA (commandite par actions)Size: ETICreation date: 1986-07-01 (39 years)Status: ActiveBusiness sector: Fabrication de parfums et de produits pour la toiletteLocation: HEROUVILLE-SAINT-CLAIR (14200), Calvados
OCEAN TERRE BIOTECHNOLOGIE : revenue, balance sheet and financial ratios
OCEAN TERRE BIOTECHNOLOGIE is a French company
founded 39 years ago,
specialized in the sector Fabrication de parfums et de produits pour la toilette.
Based in HEROUVILLE-SAINT-CLAIR (14200),
this company of category ETI
shows in 2020 a revenue of 34.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - OCEAN TERRE BIOTECHNOLOGIE (SIREN 338346901)
Indicator
2020
2019
2018
2017
2016
2015
Revenue
34 363 964 €
44 801 159 €
67 558 248 €
67 560 659 €
66 356 597 €
60 345 149 €
Net income
-1 083 796 €
1 000 633 €
3 559 973 €
-643 112 €
-926 310 €
236 836 €
EBITDA
119 110 €
4 348 071 €
-3 114 939 €
2 492 494 €
2 006 646 €
1 944 170 €
Net margin
-3.2%
2.2%
5.3%
-1.0%
-1.4%
0.4%
Revenue and income statement
In 2020, OCEAN TERRE BIOTECHNOLOGIE achieves revenue of 34.4 M€. Revenue is declining over the period 2015-2020 (CAGR: -10.7%). Significant drop of -23% vs 2019. After deducting consumption (17.0 M€), gross margin stands at 17.4 M€, i.e. a rate of 51%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 119 k€, representing 0.3% of revenue. Warning negative scissor effect: despite revenue change (-23%), EBITDA varies by -97%, reducing margin by 9.4 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -1.1 M€ (-3.2% of revenue), which will impact equity.
Revenue (2020)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
34 363 964 €
Gross margin (2020)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
17 364 196 €
EBITDA (2020)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
119 110 €
EBIT (2020)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-1 065 530 €
Net income (2020)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-1 083 796 €
EBITDA margin (2020)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
0.3%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 147%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 26%. The balance between equity and debt is satisfactory.
Debt ratio (2020)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
147.045%
Financial autonomy (2020)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
25.78%
Cash flow / Revenue (2020)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
-2.638%
Repayment capacity (2020)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
-10.017
Asset age ratio (2020)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
Debt ratio
261.762
305.437
313.628
86.919
49.348
147.045
Financial autonomy
16.331
14.843
14.489
28.876
27.681
25.78
Repayment capacity
9.771
11.51
10.915
-1.477
3.093
-10.017
Cash flow / Revenue
2.277%
2.115%
2.229%
-5.468%
2.588%
-2.638%
Sector positioning
Debt ratio
147.042020
2018
2019
2020
Q1: 0.03
Med: 25.94
Q3: 103.36
Watch
In 2020, the debt ratio of OCEAN TERRE BIOTECHNOLOGIE (147.04) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
25.78%2020
2018
2019
2020
Q1: 15.87%
Med: 38.63%
Q3: 61.02%
Average
In 2020, the financial autonomy of OCEAN TERRE BIOTECHNOLOGIE (25.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
-10.02 years2020
2018
2019
2020
Q1: 0.0 years
Med: 0.05 years
Q3: 2.11 years
Excellent
In 2020, the repayment capacity of OCEAN TERRE BIOTECHNOLOGIE (-10.02) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 169.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 28.8x. Operating income very largely covers interest expenses: high safety margin.
Liquidity ratio (2020)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
169.411
Interest coverage (2020)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
Liquidity ratio
192.699
187.54
178.238
149.581
111.572
169.411
Interest coverage
6.185
6.643
4.161
-3.055
0.71
28.771
Sector positioning
Liquidity ratio
169.412020
2018
2019
2020
Q1: 141.21
Med: 240.24
Q3: 381.4
Average
In 2020, the liquidity ratio of OCEAN TERRE BIOTECHNOLOGIE (169.41) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
28.77x2020
2018
2019
2020
Q1: 0.0x
Med: 0.34x
Q3: 3.84x
Excellent+52 pts over 3 years
In 2020, the interest coverage of OCEAN TERRE BIOTECHNOLOGIE (28.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 56 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 79 days. Favorable situation: supplier credit is longer than customer credit by 23 days. Inventory turnover is 44 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 135 days of revenue, i.e. 12.9 M€ to permanently finance. Notable WCR improvement over the period (-34%), freeing up cash.
Operating WCR (2020)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
12 908 823 €
Customer credit (2020)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
56 j
Supplier credit (2020)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
79 j
Inventory turnover (2020)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
44 j
WCR in days of revenue (2020)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
135 j
WCR and payment terms evolution OCEAN TERRE BIOTECHNOLOGIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
Operating WCR
19 537 345 €
21 317 057 €
19 754 737 €
12 595 560 €
15 074 246 €
12 908 823 €
Inventory turnover (days)
54
44
46
22
32
44
Customer payment term (days)
68
76
70
39
65
56
Supplier payment term (days)
61
69
70
51
120
79
Positioning of OCEAN TERRE BIOTECHNOLOGIE in its sector
Comparison with sector Fabrication de parfums et de produits pour la toilette
Valuation estimate
Based on 74 transactions of similar company sales
(all years),
the value of OCEAN TERRE BIOTECHNOLOGIE is estimated at
1 462 035 €
(range 937 834€ - 3 327 787€).
With an EBITDA of 119 110€, the sector multiple of 0.6x is applied.
The price/revenue ratio is 0.11x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2020
74 tx
937k€1462k€3327k€
1 462 035 €Range: 937 834€ - 3 327 787€
Section all-time
Aggregated at NAF section level
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
119 110 €×0.6x
Estimation74 447 €
22 554€ - 171 677€
Revenue Multiple30%
34 363 964 €×0.11x
Estimation3 774 684 €
2 463 302€ - 8 587 971€
How is this estimate calculated?
This estimate is based on the analysis of 74 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Fabrication de parfums et de produits pour la toilette)
Compare OCEAN TERRE BIOTECHNOLOGIE with other companies in the same sector:
Frequently asked questions about OCEAN TERRE BIOTECHNOLOGIE
What is the revenue of OCEAN TERRE BIOTECHNOLOGIE ?
The revenue of OCEAN TERRE BIOTECHNOLOGIE in 2020 is 34.4 M€.
Is OCEAN TERRE BIOTECHNOLOGIE profitable?
OCEAN TERRE BIOTECHNOLOGIE recorded a net loss in 2020.
Where is the headquarters of OCEAN TERRE BIOTECHNOLOGIE ?
The headquarters of OCEAN TERRE BIOTECHNOLOGIE is located in HEROUVILLE-SAINT-CLAIR (14200), in the department Calvados.
Where to find the tax return of OCEAN TERRE BIOTECHNOLOGIE ?
The tax return of OCEAN TERRE BIOTECHNOLOGIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does OCEAN TERRE BIOTECHNOLOGIE operate?
OCEAN TERRE BIOTECHNOLOGIE operates in the sector Fabrication de parfums et de produits pour la toilette (NAF code 20.42Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart